Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center">Correlation coefficient</td><td align="center"><i>P</i></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Ferritin</td><td align="center">0.240</td><td align="center">.153</td></tr><tr><td align="left">IL-6</td><td align="center">0.163</td><td align="center">.335</td></tr><tr><td align="left">CRP</td><td align="center">0.093</td><td align="center">.505</td></tr><tr><td align="left">Hepcdin-25</td><td align="center">0.575</td><td align="center">&lt;.001</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Correlations between serum hepcidin-20 levels, inflammation indices, and serum hepcidin-25 in HD patients.

BioMed Research International

tab3

Table 3

Table 3: Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS 